Haemophilia Treatment Market: By Type, By Products, By Distribution Channel, and Region Forecast 2019-2030

Haemophilia Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), By Products (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin and Antifibrinolytic Agents), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Region Forecast 2019-2030

Haemophilia Treatment Market size was valued at US$ 9,834.7 million in 2023 and is projected to reach US$ 15,387.3 million by 2030, growing at a 5.2% CAGR from 2024 to 2030. Hemophilia is an inherited bleeding disorder that is caused by the lack of clotting proteins, a patient suffering from hemophilia bleeds longer than usual or even bleeds internally. The primary treatment for is to replace the missing clotting factor through intravenous infusion. The rising prevalence of hemophilia across the world and technological advancement in medications drive market growth.

According to the Centres for disease control and Prevention, Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia, each year, as many as 33,000 males in the United States are living with the disorder. The growing adoption of prophylaxis treatment and the upsurge of hemophilia prevalence in newborns enhance the market growth. The government initiatives for the promotion of hemophilia treatment and increase in research and development on identifying therapeutic agent consequences lucrative opportunities in the market. The increased cost of medications and rising adverse reactions of plasma treatment products are the major factors limiting market growth.

Haemophilia Treatment Market Key Developments

  • In February 2023, The U.S. Food and Drug Administration (FDA) approved ALTUVIIIO™ [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], previously referred to as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement therapy.
  • In May 2022, Takeda launched Adynovate for the prophylaxis treatment of hemophilia patients in India. Adynovate, combined with MYPKFIT, the first and only FDA-approved application, offers personalized and interactive prophylaxis treatment options.

Haemophilia Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific

HaemophiliaTreatment Market Dynamics

The increasing prevalence of hemophilia patients across the world is the major market driver in the hemophilia treatment market during the forecast period. Hemophilia is caused when blood is unable to clot properly, excessive bleeding occurs after an injury. The rising prevalence of hemophilia observed in the past years, the continuous research and development activities enhance the market growth, in recent studies the current population of males with hemophilia in the United States is estimated to be between 30,000 to 33,000 consequences of high demand for therapeutic agents to prevent from hemophilia. Technological advancement in healthcare for diagnosis drives market growth at a significant rate.

Haemophilia Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 9,834.7 million

Market Size in 2030

US$ 15,387.3 million

Market CAGR

9.8%

By Type

  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
  • Others

By Products

  • Plasma-Derived Coagulation Factor Concentrates
  • Recombinant Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytic Agents

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The haemophilia treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis  

Download Free Sample Report

Frequently Asked Questions

The global haemophilia treatment market size was valued at US$ 9,834.7 million in 2023 and is set to reach US$ 15,387.3 million by 2030, at a CAGR of 5.2%

The leading players in the haemophilia treatment market are Baxter, Grifols S.A., CSL Limited, Octapharma, Novo Nordisk A/S, Kedrion S.p.A, Pfizer Inc., Bayer AG, Biogen, Shire, F. Hoffmann-La Roche Ltd, Ferring B.V., Sanofi, Swedish Orphan Biovitrum AB (publ), BioMarin, and Sangamo Therapeutics,

2019 - 2023 and Forecast 2024 - 2030

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Haemophilia Treatment Market Introduction 
2.1.Global Haemophilia Treatment Market  - Taxonomy
2.2.Global Haemophilia Treatment Market  - Definitions
2.2.1.Type
2.2.2.Product Type
2.2.3.Distribution Channel
2.2.4.Region
3.Global Haemophilia Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Haemophilia Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Haemophilia Treatment Market  By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Hemophilia A
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Hemophilia B
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Hemophilia C
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Haemophilia Treatment Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Plasma-Derived Coagulation Factor Concentrates
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Recombinant Coagulation Factor Concentrates
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Desmopressin
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Antifibrinolytic Agents
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Haemophilia Treatment Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacy
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacy
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacy
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Haemophilia Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Haemophilia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hemophilia A
9.1.2.Hemophilia B
9.1.3.Hemophilia C
9.1.4.Others
9.2.  Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Plasma-Derived Coagulation Factor Concentrates
9.2.2.Recombinant Coagulation Factor Concentrates
9.2.3.Desmopressin
9.2.4.Antifibrinolytic Agents
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacy
9.3.2.Retail Pharmacy
9.3.3.Online Pharmacy
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Haemophilia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hemophilia A
10.1.2.Hemophilia B
10.1.3.Hemophilia C
10.1.4.Others
10.2.  Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Plasma-Derived Coagulation Factor Concentrates
10.2.2.Recombinant Coagulation Factor Concentrates
10.2.3.Desmopressin
10.2.4.Antifibrinolytic Agents
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacy
10.3.2.Retail Pharmacy
10.3.3.Online Pharmacy
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Haemophilia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hemophilia A
11.1.2.Hemophilia B
11.1.3.Hemophilia C
11.1.4.Others
11.2.  Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Plasma-Derived Coagulation Factor Concentrates
11.2.2.Recombinant Coagulation Factor Concentrates
11.2.3.Desmopressin
11.2.4.Antifibrinolytic Agents
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacy
11.3.2.Retail Pharmacy
11.3.3.Online Pharmacy
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Haemophilia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hemophilia A
12.1.2.Hemophilia B
12.1.3.Hemophilia C
12.1.4.Others
12.2.  Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Plasma-Derived Coagulation Factor Concentrates
12.2.2.Recombinant Coagulation Factor Concentrates
12.2.3.Desmopressin
12.2.4.Antifibrinolytic Agents
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacy
12.3.2.Retail Pharmacy
12.3.3.Online Pharmacy
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Haemophilia Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Hemophilia A
13.1.2.Hemophilia B
13.1.3.Hemophilia C
13.1.4.Others
13.2.  Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Plasma-Derived Coagulation Factor Concentrates
13.2.2.Recombinant Coagulation Factor Concentrates
13.2.3.Desmopressin
13.2.4.Antifibrinolytic Agents
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacy
13.3.2.Retail Pharmacy
13.3.3.Online Pharmacy
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Baxter
14.2.2.Grifols S.A.
14.2.3.CSL Limited
14.2.4.Octapharma
14.2.5.Novo Nordisk A/S
14.2.6.Kedrion S.p.A
14.2.7.Pfizer Inc.
14.2.8.Bayer AG
14.2.9.Biogen
14.2.10.Shire
14.2.11.F. Hoffmann-La Roche Ltd
14.2.12.Ferring B.V.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Baxter
  • Grifols S.A.
  • CSL Limited
  • Octapharma
  • Novo Nordisk A/S
  • Kedrion S.p.A
  • Pfizer Inc.
  • Bayer AG
  • Biogen
  • Shire
  • F. Hoffmann-La Roche Ltd
  • Ferring B.V.
  • Sanofi
  • Swedish Orphan Biovitrum AB (publ)
  • BioMarin
  • Sangamo Therapeutics

Related Industry Reports